BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11160737)

  • 1. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.
    Li M; Yang C; Compans RW
    J Virol; 2001 Mar; 75(5):2337-44. PubMed ID: 11160737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
    Yang C; Compans RW
    J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
    Christodoulopoulos I; Cannon PM
    J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity.
    Yang C; Compans RW
    J Virol; 1997 Nov; 71(11):8490-6. PubMed ID: 9343206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
    Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
    Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins.
    Yang C; Yang Q; Compans RW
    J Virol; 2000 Jul; 74(13):6217-22. PubMed ID: 10846110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
    Kubo Y; Amanuma H
    J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell signaling through the protein kinases cAMP-dependent protein kinase, protein kinase Cepsilon, and RAF-1 regulates amphotropic murine leukemia virus envelope protein-induced syncytium formation.
    Wang W; Jobbagy Z; Bird TH; Eiden MV; Anderson WB
    J Biol Chem; 2005 Apr; 280(17):16772-83. PubMed ID: 15741175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein.
    Thomas A; Gray KD; Roth MJ
    Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression.
    Li M; Yang C; Tong S; Weidmann A; Compans RW
    J Virol; 2002 Dec; 76(23):11845-52. PubMed ID: 12414927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Linked glycosylation is required for XC cell-specific syncytium formation by the R peptide-containing envelope protein of ecotropic murine leukemia viruses.
    Kubo Y; Ishimoto A; Amanuma H
    J Virol; 2003 Jul; 77(13):7510-6. PubMed ID: 12805451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry.
    Burkhart MD; D'Agostino P; Kayman SC; Pinter A
    J Virol; 2005 Jun; 79(12):7868-76. PubMed ID: 15919941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of R-peptides in envelope proteins of C-type retroviruses.
    Bobkova M; Stitz J; Engelstädter M; Cichutek K; Buchholz CJ
    J Gen Virol; 2002 Sep; 83(Pt 9):2241-2246. PubMed ID: 12185279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Spies CP; Compans RW
    Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell fusion induced by the murine leukemia virus envelope glycoprotein.
    Jones JS; Risser R
    J Virol; 1993 Jan; 67(1):67-74. PubMed ID: 8416389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain.
    Taylor GM; Sanders DA
    Virology; 2003 Aug; 312(2):295-305. PubMed ID: 12919735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.